Home › Trial NCT03030625
VMAT for Dominant Intraprostatic Lesion
- Trial IDNCT03030625
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorFundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Enrollment30
- Start date2017-03-13
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.